Robert J. Temple, MD
- 5Articles
- 23.6KReads1
- 2011–2017Active
- 37Collaborators
- 161Citations2
About
Robert J. Temple, MD, has published extensively on topics related to depression and neurology, with a focus on regulatory perspectives and clinical evaluations of antidepressant and antipsychotic medications. His work includes analyses of the FDA's views on new drugs such as pimavanserin, vortioxetine, and vilazodone, as well as studies addressing sexual dysfunction in antidepressant trials. Temple's articles, published between 2011 and 2017, contribute to understanding regulatory science in psychiatric medication development.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
